Crestor
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
23 Rockview Dr, Santa Cruz, California, ...Phone Number
(831) 475-4435Website
www.crestor.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Crestor
AstraZeneca Pharmaceuticals LP offers CRESTOR® (rosuvastatin), a cholesterol-lowering medication designed to reduce the risk of heart attacks and strokes in adults with elevated cholesterol levels. The product is intended for US consumers and healthcare professionals, providing information on its approved uses, dosage, and potential side effects. CRESTOR is particularly aimed at high-risk patients, including those with familial hypercholesterolemia and other cholesterol-related conditions. The company also provides resources such as a savings card for eligible patients to help manage the cost of the medication.Explore more
Crestor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crestor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Crestor, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Crestor recently announced quarterly report
Click to see if Crestor had a recent Job posting/layoffs
Check if Crestor has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Crestor has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Crestor
Check out if Crestor is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Crestor launches new products
Recommended Actions
Reach out to Masked Content who joined Crestor as Masked Content
Find more new buyers
Compare Similar Companies to Crestor
Compare insights from companies similar to Crestor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Crestor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Crestor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Crestor.
Crestor Tech Stack
A closer look at the technologies used by Crestor
Crestor News & Media
Divestment of Crestor in Europe to Grünenthal completed
10 February 2021 07:00 GMT Divestment of Crestor in Europe to Grünenthal completed AstraZeneca has completed the divestment of the rights to (https://www.astrazeneca.com/media-centre/press-releases/2020/crestor-to-be-divested-to-grunenthal-in-europe.html)Crestor (https://www.astrazeneca.com/media-centre/press-releases/2020/crestor-to-be-divested-to-grunenthal-in-europe.html)(rosuvastatin) and associated medicines in over 30 countries in Europe to Grünenthal GmbH (Grünenthal). Rights in the UK anGrünenthal agrees to acquire European rights to CRESTOR™ (rosuvastatin) from AstraZeneca
AACHEN, Germany, Dec. 1, 2020 /PRNewswire/ -- Grünenthal, a global science-based, privately-owned pharmaceutical company, today announced that it has agreed to acquire the European rights (excluding Spain and the UK) to CRESTOR™ (rosuvastatin) and its associated brands for a total...Crestor to be divested to Grünenthal in Europe
1 December 2020 07:00 GMT Crestor to be divested to Grünenthal in Europe AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe, except the UK and Spain, to Grünenthal GmbH (Grünenthal). Crestor is a statin approved for the treatment of dyslipidaemia and hypercholesterolaemia. Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, said: "This agreement supports the management of our mature medicines to enable
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crestor
Sign Up For FreeTo access detailed company insights
AstraZeneca Pharmaceuticals LP offers CRESTOR® (rosuvastatin), a cholesterol-lowering medication designed to reduce the risk of heart attacks and strokes in adults with elevated cholesterol levels. The product is intended for US consumers and healthcare professionals, providing information on its approved uses, dosage, and potential side effects. C... Read More
